Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Botox
maker not liable in girl's death 5:22 AM 3/3/2010
Los Angeles Times
A jury declined to hold botulinum toxin-based Botox maker Allergan Inc liable in the death of a Texas girl being treated for cerebral palsy. It found the product's warning label was adequate.
...
Abbott,
Enanta moving Hepatitis C drug development 10:38 AM 3/2/2010
BusinessWeek
Abbott Laboratories and partner Enanta Pharmaceuticals will move potential hepatitis C treatments ABT-450, ABT-333, and ABT-072 into midstage development.
...
Biodel
says FDA accepts diabetes drug application 10:25 AM 3/1/2010
Reuters
The US FDA accepted Biodel Inc's marketing application for its experimental diabetes drug VIAject formulation of human insulin designed to be quickly absorbed into the blood.
...
FDA
accepts Vivus application for obesity drug 9:27 AM 3/1/2010
MarketWatch
Vivus Inc said the US FDA accepted its application to market its new anti-obesity drug Qnexa.
...
Aeterna's
blood cancer drug gets European nod 7:34 AM 3/1/2010
Reuters
Aeterna Zentaris Inc said European health regulators granted its perifosine blood cancer treatment orphan drug status.
...
Ariad
gets orphan drug designation 7:24 AM 3/1/2010
Boston Globe
Ariad Pharmaceuticals Inc's investigational pan-BCR-ABL inhibitor AP24534 has been granted orphan drug designation by both the US FDA and the European Medicines Agency.
...
Astellas
offers to buy OSI Pharma for $3.5 billion 6:36 AM 3/1/2010
Reuters
Japan's Astellas Pharma Inc offered to buy OSI Pharmaceuticals to gain access to OSI's cancer drug Tarceva.
...
Merck
KGaA to buy Millipore for $7.2 billion 5:55 AM 3/1/2010
MarketWatch
Merck KGaA will buy biotech-equipment maker Millipore Corp topping a rival offer from Thermo Fisher Scientific.
...
Actelion's
key drug fails pulmonary fibrosis study 5:16 AM 3/1/2010
Reuters
Actelion's drug Tracleer failed to help reduce mortality in patients suffering from idiopathic pulmonary fibrosis.
...
Brain
images suggest Alzheimer's drug is working 3:30 PM 2/28/2010
Reuters
Pfizer Inc, Elan Corp, and Johnson & Johnson are developing Bapineuzumab to treat the underlying cause of the degenerative brain disease.
...
Gene
links to celiac disease may help drug search 9:44 AM 2/28/2010
Reuters
Scientists identified new genetic links to celiac disease. This could help the search for better ways to diagnose and treat the gluten-intolerance disorder.
...
US
approves Shire's drug for Gaucher disease 10:29 AM 2/26/2010
Reuters
The US FDA approved Shire Plc's Vpriv drug to treat children and adults with the most common form of Gaucher disease.
...
Roche's
Avastin Drug Stalls Ovarian Cancer in Study 12:51 PM 2/25/2010
BusinessWeek
Roche Holding's Avastin tumor drug kept ovarian cancer at bay in a clinical trial when combined with chemotherapy.
...
Sunesis
to advance cancer drug development, shares rise 8:37 AM 2/25/2010
Reuters
Sunesis Pharmaceuticals Inc plans to start a late-stage trial of its experimental cancer drug voreloxin in the second half of 2010 in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia.
...
Theratechnologies
says FDA delays fat drug review meet 7:27 AM 2/25/2010P
Reuters
Theratechnologies Inc said the US FDA will extend the review date of its experimental drug tesamorelin to treat HIV-associated excess abdominal fat.
...
<- Day Earlier | Today's News
|
